Controlled Substances Importer; Application

Federal Register: March 19, 2008 (Volume 73, Number 54)

Notices

Page 14839-14840

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr19mr08-86

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances; Notice of Application

Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing.

Therefore, in accordance with Title 21 Code of Federal Regulations

(CFR), 1301.34(a), this is notice that on February 29, 2008, AllTech

Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II:

Drug

Schedule

Cocaine (9041)............................. II

Codeine (9050)............................. II

Hydrocodone (9193)......................... II

Meperidine (9230).......................... II

Methadone (9250)........................... II

Morphine (9300)............................ II

The company plans to import these controlled substances for the manufacture of reference standards.

Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled

Page 14840

substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47.

Any such comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration,

Office of Diversion Control, Federal Register Representative (ODL),

Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control,

Federal Register Representative (ODL), 8701 Morrissette Drive,

Springfield, VA 22152; and must be filed no later than April 18, 2008.

This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c),

(d), (e) and (f). As noted in a previous notice published in the

Federal Register on September 23, 1975, (40 FR 43745), all applicants for registration to import a basic class of any controlled substances in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion

Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.

Dated: March 11, 2008.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug

Enforcement Administration.

FR Doc. E8-5525 Filed 3-18-08; 8:45 am

BILLING CODE 4410-09-P